Montelukast chewable pills 5 mg 28 pcs
Condition: New product
1000 Items
Rating:
Be the first to write a review!
More info
Active ingredients
Montelukast
Release form
Pills
Composition
1 tab. montelukast sodium 5.2 mg, which corresponds to the content of montelukast 5 mg. Excipients: mannitol - 203.
Indications
- prevention and long-term treatment of asthma, including the prevention of day and night symptoms of the disease - treatment of bronchial asthma in patients with hypersensitivity to acetylsalicylic acid - prevention of bronchospasm caused by exercise - relief of daytime and nighttime symptoms of seasonal allergic rhinitis and persistent allergic rhinitis.
Contraindications
- hypersensitivity to any of the components of the drug - children under 6 years old - phenylketonuria
Dosage and administration
Montelukast drug is taken orally 1 time / day, regardless of the reception of the poor. The tablet can be swallowed whole or chewed before swallowing. For the treatment of asthma, the drug should be taken in the evening. When treating allergic rhinitis, the drug can be taken at any time of the day. Patients with asthma and allergic rhinitis should take 1 tablet 1 time / day in the evening. Children aged 6 to 14 years 1 tablet chewable 5 mg 1 time / day. Dose selection for this age group is not required. Children over 15 years old and adults. The dose for adults and children over 15 years old is 10 mg of Montelukast per day. The therapeutic effect of the drug Montelukast on the indicator, reflecting the course of bronchial asthma, develops during the first day. The patient should continue to take the drug in the period to achieve control of symptoms of bronchial asthma, and in the period of exacerbation of the disease. For elderly patients, patients with renal insufficiency, patients with mild or moderately impaired liver function, no special dose selection is required. Montelukast can be added to the treatment of bronchodilator and inhaled GCS.
Side effects
Side effects are usually mild and, as a rule, do not require discontinuation of the drug. From the nervous system: headache, dizziness, drowsiness, paresthesia / gynesthesia, convulsions. Since the cardiovascular system: rapid heartbeat.On the part of the respiratory system, organs of the chest and mediastinum: nasal bleeding, pulmonary eosinophilia. Mental disorders: agitation, incl. aggressive behavior or hostility, anxiety, depression, disorientation, impaired attention, pathological dreams, hallucinations. insomnia. memory impairment, psychomotor activity (including irritability, anxiety and tremor), somnambulism, suicidal thoughts and behavior (suicidality). From the side. GIT: diarrhea, dyspepsia, nausea, vomiting, pancreatitis, abdominal pain. Liver and biliary tract disorders: increased activity of ALT and ACT, hepatitis (including cholestatic, hepatocellular, and mixed liver damage). From the organs of the musculoskeletal system: arthralgia, myalgia. muscle cramps. On the part of the blood and lymphatic system: increased tendency to bleeding, thrombocytopenia. On the part of the skin and subcutaneous tissues: a tendency to the formation of hematomas, erythema nodosum, erythema multiforme, itching. rash, urticaria, angioedema. On the part of the immune system: hypersensitivity reactions, including anaphylaxis, eosiophilus infiltration of the liver. Infectious and parasitic diseases: upper respiratory tract infections. Others: asthenia (weakness) / weariness. swelling, pyrexia.